KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Payables (2016 - 2025)

Historic Payables for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $2.6 billion.

  • Medtronic's Payables rose 862.79% to $2.6 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $2.6 billion, marking a year-over-year increase of 862.79%. This contributed to the annual value of $2.4 billion for FY2025, which is 161.83% up from last year.
  • Per Medtronic's latest filing, its Payables stood at $2.6 billion for Q4 2025, which was up 862.79% from $2.6 billion recorded in Q3 2025.
  • Medtronic's Payables' 5-year high stood at $2.7 billion during Q2 2023, with a 5-year trough of $1.8 billion in Q1 2021.
  • For the 5-year period, Medtronic's Payables averaged around $2.2 billion, with its median value being $2.2 billion (2023).
  • In the last 5 years, Medtronic's Payables soared by 1695.96% in 2023 and then tumbled by 982.34% in 2024.
  • Medtronic's Payables (Quarter) stood at $1.9 billion in 2021, then increased by 14.66% to $2.2 billion in 2022, then decreased by 1.09% to $2.2 billion in 2023, then rose by 9.29% to $2.4 billion in 2024, then grew by 8.63% to $2.6 billion in 2025.
  • Its Payables stands at $2.6 billion for Q4 2025, versus $2.6 billion for Q3 2025 and $2.4 billion for Q2 2025.